Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
37 hedge funds and large institutions have $97.1M invested in Enzymotec Ltd in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.
213% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 8
138% more capital invested
Capital invested by funds: $40.7M → $97.1M (+$56.4M)
85% more funds holding
Funds holding: 20 → 37 (+17)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GF
Gabelli Funds
Rye,
New York
|
+$6.69M |
| 2 |
GH
GAM Holding
Zurich,
Switzerland
|
+$6.15M |
| 3 |
WIC
Water Island Capital
New York
|
+$4.64M |
| 4 |
WRBC
W.R. Berkley Corp
Greenwich,
Connecticut
|
+$3.2M |
| 5 |
Renaissance Technologies
New York
|
+$3.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
-$7.76M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$458K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$331K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$207K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$184K |
ENZY Hedge Fund Activity: Q4 2017 in Review
37 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q4 2017, worth a combined $97.1M — up 138% from $40.7M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new ENZY positions and 8 closed out — a net gain of 17 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Gabelli Funds, opening a new position worth an estimated $6.69M. The largest seller was Tiger Management, exiting entirely with an estimated $7.76M sold.
- 37 institutional investors held Enzymotec Ltd (ENZY) as of Q4 2017, up from 20 in Q3 2017.
- Funds reported $97.1M of Enzymotec Ltd stock for Q4 2017, up 138% quarter-over-quarter.
- 25 funds opened new Enzymotec Ltd positions in Q4 2017 and 8 closed out, a net change of +17 holders.
- The largest Enzymotec Ltd buyer in Q4 2017 was Gabelli Funds, an estimated $6.69M added.
- The largest Enzymotec Ltd seller in Q4 2017 was Tiger Management, an estimated $7.76M sold.
Based on aggregated 13F filings for Q4 2017.